Matthew Brams
Fortune : 33 933 $ au 31/05/2026
Fortune : 33 933 $ au 31/05/2026
Matthew N.
Brams is the founder of Cingulate, Inc., founded in 2012, where the title held is Chief Medical Officer & Executive Vice President.
Dr. Brams is the founder of Cingulate Works, Inc., founded in 2013, where the title held is Chief Medical Officer & Executive Vice President.
Dr. Brams is also the founder of Cingulate Therapeutics LLC..
Dr. Brams currently works at Baylor College of Medicine as a Clinical Associate Professor.
Formerly, Dr. Brams was Medical Director & Principal at Bayou City Research, Inc. from 1999 to 2021.
Education includes undergraduate studies at The University of Texas at Austin and a doctorate from The University of Texas Health Science Center at Houston.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CINGULATE, INC. 0,06% | 18/05/2026 | 8 157 ( 0,06% ) | 33 933 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CINGULATE INC. | Fondateur | 01/05/2012 |
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on develops attention deficit/hyperactivity disorder products | Fondateur | - |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for the treatment of central nervous system and neurobiological disorders | Fondateur | 01/01/2013 |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
Bayou City Research, Inc. | Directeur Technique/Scientifique/R&D | 01/01/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on develops attention deficit/hyperactivity disorder products | Health Technology |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas Health Science Center at Houston
The University of Texas Health Science Center at Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for the treatment of central nervous system and neurobiological disorders | Health Technology |
Cingulate, Inc.
Cingulate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Bayou City Research, Inc. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national